Gait and Alzheimer Interaction Tracking (GAIT) Study
GAIT
Maladie d'Alzheimer et Troubles Locomoteurs : Caracterisation Des Anomalies Temporelles de la Marche et Etude Des Correlats Anatomo-cognitifs
1 other identifier
observational
912
1 country
1
Brief Summary
The purpose of this study is to examine and to compare gait characteristics under single- and dual-task conditions among healthy subjects together with AD patients at different stages of disease (i.e., pre-dementia, mild and moderate dementia stages).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 10, 2011
CompletedFirst Posted
Study publicly available on registry
March 15, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedSeptember 22, 2016
March 1, 2011
6.5 years
March 10, 2011
September 21, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Stride-to-stride variability of stride time
baseline
Study Arms (4)
Group 1
Healthy subjects
Group 2
Patients with Mild Cognitive Impairment
Group 3
Patients with Mild AD
Group 4
Patients with Moderate AD
Eligibility Criteria
All patients of the University Memory Center of Angers Hospital with respect to the eligibility criteria.
You may qualify if:
- Age ≥ 60 years
- Able to walk without walking aid on 15 metres
- Score of Mini-Mental Examination (MMSE) \> 10
- Written informed consent to participate in the study (or trustworthy person)
- Being affiliated to a social security regime
- Near visual acuity ≥ 2/10
- Absence of severe depression (score in the 15-item Geriatric Depression Scale ≤ 10)
You may not qualify if:
- Score of Mini-Mental Examination (MMSE) ≤ 10
- Subject suffering from pre-existing impellent disturbances
- History of cerebrovascular accident or other cerebro-spinal pathology
- Poor workmanship of the written or oral French language
- Refusal of subject to be informed on possible hanging bare anomaly during study
- Use of walking aid
- Acute medical or surgical disease in the past 3 months
- Refusal to participate (or trustworthy person)
- Contra-indication to the achievement of a Magnetic Resonance Imaging
- Near visual acuity \< 2/10
- Presence of severe depression (score in the 15-item Geriatric Depression Scale \> 10)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Angers University Hospital
Angers, 49933, France
Related Publications (1)
Graffe A, Beauchet O, Fantino B, Milea D, Annweiler C. Vitamin D and macular thickness in the elderly: an optical coherence tomography study. Invest Ophthalmol Vis Sci. 2014 Jul 15;55(8):5298-303. doi: 10.1167/iovs.14-13918.
PMID: 25028353DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Beauchet, MD, PhD
Angers University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2011
First Posted
March 15, 2011
Study Start
November 1, 2009
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
September 22, 2016
Record last verified: 2011-03